Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001654954-18-000198
Filing Date
2018-01-08
Accepted
2018-01-08 17:53:42
Documents
2
Period of Report
2018-01-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 3  
1 PRIMARY DOCUMENT section16.xml 3 2941
2 POWER OF ATTORNEY poaand.htm EX-24 4833
  Complete submission text file 0001654954-18-000198.txt   9072
Mailing Address 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL 60062
Business Address 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL 60062 6143958936
Monopar Therapeutics (Issuer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SKOKIE BLVD., SUITE 350 WILMETTE IL 60091
Business Address
Anderson Kirsten (Reporting) CIK: 0001727335 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55866 | Film No.: 18517418